Subject(s)
COVID-19 , Communicable Disease Control , Population Density , Primary Prevention/standards , Basic Reproduction Number , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/transmission , Communicable Disease Control/methods , Communicable Disease Control/organization & administration , Communicable Disease Control/statistics & numerical data , Data Accuracy , Data Interpretation, Statistical , Disease Transmission, Infectious/prevention & control , Disease Transmission, Infectious/statistics & numerical data , Humans , Incidence , Risk Assessment , Risk Factors , SARS-CoV-2/isolation & purification , Severity of Illness IndexABSTRACT
The COVID-19 pandemic altered traditional education models and school nursing practice during the 2020-2021 school year. As schools plan to reopen for the 2021-2022 school year, school nurses must arm themselves with the most recent evidence-based knowledge and tools to promote the health and safety of the school community. Schools will need to continue infection control measures and strategies to support the social emotional needs of students and staff to promote a safe and healthy learning environment on return to school. Partnered with local health departments, school nurses are vital to mitigation measures such as on-site viral testing and vaccination. A successful school year depends on strong nursing leadership.
Subject(s)
COVID-19/prevention & control , COVID-19/psychology , Nursing Staff/psychology , Pandemics/prevention & control , Practice Guidelines as Topic , Primary Prevention/standards , School Nursing/standards , Adolescent , Adult , Attitude of Health Personnel , COVID-19/epidemiology , Child , Female , Humans , Male , Middle Aged , SARS-CoV-2 , United States/epidemiology , VaccinationSubject(s)
Coronavirus Infections/prevention & control , Coronavirus , Disease Transmission, Infectious/prevention & control , Guidelines as Topic , Pandemics/prevention & control , Personal Protective Equipment/standards , Pneumonia, Viral/prevention & control , Primary Prevention/standards , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Humans , Infection Control/organization & administration , Pneumonia, Viral/epidemiology , Primary Prevention/methods , SARS-CoV-2 , Safety/standards , Safety ManagementABSTRACT
Our work concerns the actual problem of spread of SARS- CoV-2 outbreak which requires fast and correct as possible answer. In current scenario, the need of rapid answer put away the imperative of proper methodology. We focus on the serogical immunoassay for diagnosis of Covid-19 as an important weapon not only for diagnostic purpose, but also for epidemiologic one. The right equilibrium between high speed, low cost and accuracy is obtained with easy-to-use decentralized point-of-care test as the colloidal gold-based immunochromatographic strip assay which detects IgM and IgG antibodies directed against SARS-CoV-2. As our aim is to evaluate the efficacy of Covid-19 rapid tests and of serological assays in real-life settings, we designed a research protocol aimed to establish how to use correctly these diagnostics, taking into account the different possible clinical and epidemiological scenarios.